Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Curr Top Dev Biol. 2011;94:77-127. doi: 10.1016/B978-0-12-380916-2.00004-8.
Neuroblastoma (NB), the most common extracranial solid tumor in childhood, is an extremely heterogeneous disease both biologically and clinically. Although significant progress has been made in identifying molecular and genetic markers for NB, this disease remains an enigmatic challenge. Since NB is thought to be an embryonal tumor that is derived from precursor cells of the peripheral (sympathetic) nervous system, understanding the development of normal sympathetic nervous system may highlight abnormal events that contribute to NB initiation. Therefore, this review focuses on the development of the peripheral trunk neural crest, the current understanding of how developmental factors may contribute to NB and on recent advances in the identification of important genetic lesions and signaling pathways involved in NB tumorigenesis and metastasis. Finally, we discuss how future advances in identification of molecular alterations in NB may lead to more effective, less toxic therapies, and improve the prognosis for NB patients.
神经母细胞瘤(NB)是儿童期最常见的颅外实体瘤,在生物学和临床上均具有高度异质性。尽管在鉴定 NB 的分子和遗传标志物方面已经取得了重大进展,但这种疾病仍然是一个神秘的挑战。由于 NB 被认为是一种源自周围(交感)神经系统前体细胞的胚胎性肿瘤,因此了解正常交感神经系统的发育可能会突出导致 NB 起始的异常事件。因此,本综述重点介绍外周干神经嵴的发育,目前对发育因素如何有助于 NB 的理解,以及最近在鉴定参与 NB 肿瘤发生和转移的重要遗传病变和信号通路方面的进展。最后,我们讨论了未来在 NB 分子改变鉴定方面的进展如何可能导致更有效、毒性更小的治疗方法,并改善 NB 患者的预后。